Economic considerations of Alzheimer's disease and related disorders

Economic analyses of geriatric syn dromes are seldom performed. However, de mographic and epidemiological imperatives have led to significant interest in the evaluation of AD-related costs. Over 300 papers devoted to economic considerations of Alzheimer's disease have been published in peer-reviewed journals, within the last five years. In these papers, the chosen perspecti ve (costs to society or to specific payers) is important. Analytical method s are still evolving and re main complex. Unresolved methodological issues will need to be addressed to further our understanding of long-term economi c consequences. At present, it is clear that diagnostic and drug costs are low compared to the major cost of institutionalization. Thus, directing eff orts at early diagnosis and delaying nursing home placement are two key cos t-containment interventions. In this respect, the need to support informal care should not be underestimated. (C) 2001, Editrice Kurtis.